Liposomal Bupivacaine Versus 0.25% Bupivacaine Hydrochloride for Postoperative Analgesia After Breast Reduction Surgery: A Prospective, Single Blind, Non-randomized Controlled Trial
Latest Information Update: 05 Feb 2025
At a glance
- Drugs Bupivacaine (Primary) ; Bupivacaine
- Indications Postoperative pain
- Focus Therapeutic Use
Most Recent Events
- 30 Jan 2025 Planned End Date changed from 1 Dec 2024 to 1 Dec 2025.
- 30 Jan 2025 Planned primary completion date changed from 1 Dec 2024 to 1 Dec 2025.
- 15 Apr 2024 Status changed from not yet recruiting to recruiting.